3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
14
Breast Neoplasms
14
Neoplasms
10
Head and Neck Neoplasms
8
Carcinoma, Squamous Cell
8
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Glioblastoma
7
Colorectal Neoplasms
7
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Recurrence
5
Pancreatic Neoplasms
5
Melanoma
5
Leukemia
5
Prostatic Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Rectal Neoplasms
3
Lymphoma, Follicular
3
Colonic Neoplasms
3
Brain Neoplasms
3
Treatment
2
Sarcoma
2
Pleural Effusion, Malignant
2
Pharyngeal Neoplasms
2
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Drug Therapy
×
Clear all
No trials found.